Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

14.45
Delayed Data
As of Jun 23
 0.00 / 0.00%
Today’s Change
8.06
Today|||52-Week Range
17.20
+18.93%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close14.45
Today’s open14.40
Day’s range14.20 - 14.65
Volume1,187,043
Average volume (3 months)655,192
Market cap$703.4M
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-738.46%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+271.30%
P/E ratio180.6
Price/Sales4.86
Price/Book6.22

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...-0.20-1.24%
HSKAHeska Corp-1.11-1.13%
ENTAEnanta Pharmaceutica...+0.43+1.16%
DEPODepomed Inc+0.02+0.18%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$106.4M
Annual profit (last year)$16.5M
Net profit margin15.46%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Barabari Sharon A. Surrey
Corporate headquarters
South San Francisco, California

Forecasts